You Are Here: Home > About Arthritis > Arthritis in the News > Addition of Cosentyx® to drug plans across Canada expands access to treatment

Addition of Cosentyx® to drug plans across Canada expands access to treatment

Several provinces will now reimburse Cosentyx® (secukinumab) under the province's public drug program for eligible adults with PsA and AS.Back to News